• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗孕激素RU486在兔子宫内膜中的作用机制。RU486对孕激素受体及子宫珠蛋白基因表达的影响。

Mechanism of action of an antiprogesterone, RU486, in the rabbit endometrium. Effects of RU486 on the progesterone receptor and on the expression of the uteroglobin gene.

作者信息

Rauch M, Loosfelt H, Philibert D, Milgrom E

出版信息

Eur J Biochem. 1985 Apr 15;148(2):213-8. doi: 10.1111/j.1432-1033.1985.tb08827.x.

DOI:10.1111/j.1432-1033.1985.tb08827.x
PMID:3987685
Abstract

RU486 is a recently described antiprogesterone. In order to be able to understand its mechanism of action it is necessary to analyze its effect on a discrete gene product. We show here that the induction of uteroglobin mRNA by progesterone in the rabbit endometrium may be a suitable model for such studies since RU486 totally inhibits this effect without itself exerting any agonistic activity. Moreover, RU486, which does not bind to the estrogen receptor and is devoid of general antiestrogenic activity, partially inhibits the induction by estradiol of uteroglobin mRNA. Studies of the interaction between [3H]RU486 and the progesterone receptor have been undertaken with the aim of understanding the antagonistic effect of this compound. The binding to DNA-cellulose of heat-activated [3H]RU486-receptor complexes was slightly decreased (37%) when compared with that of the agonist [3H]R5020-receptor complexes (47%). Detailed analysis of this difference showed that it was due to both a decreased activation of complexes and to a diminished affinity of activated complexes towards DNA. The change in activation was shown by the fact that at high concentrations of DNA, where all activated complexes are bound, agonist-receptor complexes were bound to DNA in higher proportion than antagonist-receptor complexes. Moreover a difference was also observed when studying the binding of agonist-receptor and antagonist-receptor complexes to charged resins (phosphocellulose, DEAE-cellulose) which are known to discriminate between activated and non-activated complexes. Decreased affinity to DNA of antagonist-receptor complexes was shown by studying their binding at various concentrations of DNA, either in crude cytosol or after isolating a homogenous population of activated-receptor complexes by DNA-cellulose chromatography and by comparing the salt extraction from DNA-cellulose of agonist-receptor and antagonist-receptor complexes. Both effects (decreased activation and diminished affinity towards DNA) were relatively moderate and could account only for a small decrease in the agonistic activity of RU486. Thus, the fact that this compound is a complete antagonist without any agonistic activity can only be explained by a defect in some further step of hormone action as, for instance in the specific interaction with the regulatory regions of the uteroglobin gene. No immunological difference could be detected between [3H]R5020-receptor and [3H]RU486-receptor complexes, both interacted with the five monoclonal antibodies raised against purified R5020-receptor complexes.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

RU486是一种最近被描述的抗孕激素。为了能够理解其作用机制,有必要分析其对一种特定基因产物的影响。我们在此表明,孕酮对兔子宫内膜中子宫珠蛋白mRNA的诱导作用可能是此类研究的一个合适模型,因为RU486完全抑制了这种作用,而自身不发挥任何激动活性。此外,RU486不与雌激素受体结合且无一般抗雌激素活性,它部分抑制了雌二醇对子宫珠蛋白mRNA的诱导作用。为了理解该化合物的拮抗作用,已对[3H]RU486与孕酮受体之间的相互作用进行了研究。与激动剂[3H]R5020 - 受体复合物(47%)相比,热激活的[3H]RU486 - 受体复合物与DNA - 纤维素的结合略有下降(37%)。对这种差异的详细分析表明,这是由于复合物的激活减少以及激活后的复合物对DNA的亲和力降低所致。激活的变化体现在以下事实上:在高浓度DNA(此时所有激活的复合物都已结合)的情况下,激动剂 - 受体复合物与DNA结合的比例高于拮抗剂 - 受体复合物。此外,在研究激动剂 - 受体和拮抗剂 - 受体复合物与已知能区分激活和未激活复合物的带电树脂(磷酸纤维素、二乙氨基乙基纤维素)的结合时,也观察到了差异。通过研究拮抗剂 - 受体复合物在不同浓度DNA下的结合情况,无论是在粗制胞质溶胶中,还是在通过DNA - 纤维素色谱法分离出均匀的激活受体复合物群体后,并比较从DNA - 纤维素中提取激动剂 - 受体和拮抗剂 - 受体复合物的盐析情况,表明拮抗剂 - 受体复合物对DNA的亲和力降低。这两种效应(激活减少和对DNA的亲和力降低)都相对较小,仅能解释RU486激动活性的小幅下降。因此,该化合物是一种完全拮抗剂且无任何激动活性这一事实,只能通过激素作用的某些进一步步骤中的缺陷来解释,例如在与子宫珠蛋白基因调控区域的特异性相互作用中。在[3H]R5020 - 受体和[3H]RU486 - 受体复合物之间未检测到免疫差异,二者都能与针对纯化的R5020 - 受体复合物产生的五种单克隆抗体相互作用。(摘要截取自400字)

相似文献

1
Mechanism of action of an antiprogesterone, RU486, in the rabbit endometrium. Effects of RU486 on the progesterone receptor and on the expression of the uteroglobin gene.抗孕激素RU486在兔子宫内膜中的作用机制。RU486对孕激素受体及子宫珠蛋白基因表达的影响。
Eur J Biochem. 1985 Apr 15;148(2):213-8. doi: 10.1111/j.1432-1033.1985.tb08827.x.
2
The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.抗孕激素RU486可使兔子宫胞质溶胶孕酮受体的异源寡聚体、非DNA结合8S形式稳定。
Steroids. 1989 Jan-Feb;53(1-2):1-20. doi: 10.1016/0039-128x(89)90142-6.
3
Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.R5020和RU486与小牛子宫孕酮受体结合的特性研究
Biochemistry. 1988 May 17;27(10):3618-23. doi: 10.1021/bi00410a014.
4
Sequence-specific DNA binding of the progesterone receptor to the uteroglobin gene: effects of hormone, antihormone and receptor phosphorylation.孕酮受体与子宫珠蛋白基因的序列特异性DNA结合:激素、抗激素及受体磷酸化的影响
EMBO J. 1986 Dec 1;5(12):3235-41. doi: 10.1002/j.1460-2075.1986.tb04634.x.
5
Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
J Biol Chem. 1989 Feb 5;264(4):2203-11.
6
Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.小牛子宫孕酮受体的转化:受体与孕酮及RU38486结合时的过程分析
Biochemistry. 1987 Aug 11;26(16):4993-5001. doi: 10.1021/bi00390a017.
7
Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.新型抗孕激素Org 31806和31710:与哺乳动物孕酮受体的相互作用及抗类固醇受体复合物的DNA结合
J Steroid Biochem Mol Biol. 1992 Aug;42(7):695-704. doi: 10.1016/0960-0760(92)90110-5.
8
Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).在孕激素(R5020)和抗孕激素(RU486)存在的情况下人孕激素受体的转化
J Steroid Biochem. 1988 Nov;31(5):777-83. doi: 10.1016/0022-4731(88)90286-5.
9
RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.RU486是一种孕激素拮抗剂,它能与人类子宫内膜癌细胞系中的孕激素受体结合,并逆转孕激素对细胞生长的抑制作用。
J Steroid Biochem. 1988 Aug;31(2):161-6. doi: 10.1016/0022-4731(88)90049-0.
10
Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.抗雌激素与抗孕激素对转化和未转化甾体受体的影响。
J Steroid Biochem Mol Biol. 1991 Feb;38(2):197-203. doi: 10.1016/0960-0760(91)90126-p.

引用本文的文献

1
Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics.米非司酮诱导人转移性癌细胞的细胞静止和形态变化涉及细胞骨架丝状肌动蛋白的重组和细胞黏附动力学的损害。
BMC Cancer. 2013 Jan 26;13:35. doi: 10.1186/1471-2407-13-35.
2
Drug Repurposing for Cancer Therapy.用于癌症治疗的药物重新利用。
J Cancer Sci Ther. 2012 Jul 21;4(7):ix-xi. doi: 10.4172/1948-5956.1000e108.
3
Sequence-specific DNA binding of the progesterone receptor to the uteroglobin gene: effects of hormone, antihormone and receptor phosphorylation.
孕酮受体与子宫珠蛋白基因的序列特异性DNA结合:激素、抗激素及受体磷酸化的影响
EMBO J. 1986 Dec 1;5(12):3235-41. doi: 10.1002/j.1460-2075.1986.tb04634.x.
4
Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.
Drugs. 1988 Mar;35(3):187-91. doi: 10.2165/00003495-198835030-00001.
5
Contragestion by antiprogestin RU 486: a review.
Arch Gynecol Obstet. 1987;241(2):73-85. doi: 10.1007/BF00931228.
6
Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486.子宫上皮细胞凋亡的细胞死亡动力学特征以及孕酮和米非司酮对其的调节作用
Am J Pathol. 1992 Feb;140(2):449-56.
7
Molecular mechanism of RU 486 action: a review.RU 486作用的分子机制:综述
Mol Cell Biochem. 1992 Jan 15;109(1):1-8. doi: 10.1007/BF00230867.